Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739241 | 12573924 | 1 | I | 20160629 | 20160708 | 20160720 | 20160720 | EXP | GB-MHRA-TPP30327262C2184703YC1467207282353 | GB-TEVA-676634ACC | TEVA | 16.00 | YR | F | Y | 50.00000 | KG | 20160720 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739241 | 12573924 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | U | U | 62497 | ||||||||||
| 125739241 | 12573924 | 2 | C | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | 1 DOSAGE FORMS DAILY; BEFORE BEDTIME | 109.958333 | DF | 0 | 1 | DF | QD | ||||||
| 125739241 | 12573924 | 3 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 2 DOSAGE FORMS DAILY; | 2 | DF | 0 | 1 | DF | Q12H | ||||||
| 125739241 | 12573924 | 4 | C | DEPO-PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | USE AS DIRECTED | 0 | |||||||||||
| 125739241 | 12573924 | 5 | C | HYOSCINE BUTYLBROMIDE | BUTYLSCOPOLAMINE | 1 | 3 DOSAGE FORMS DAILY; | 593.875 | DF | 0 | 1 | DF | TID | ||||||
| 125739241 | 12573924 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 2 DOSAGE FORMS DAILY; | 758 | DF | 0 | 1 | DF | BID | ||||||
| 125739241 | 12573924 | 7 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | USE AS DIRECTED | 0 | |||||||||||
| 125739241 | 12573924 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 1 DOSAGE FORMS DAILY; EACH MORNING | 484.958333 | DF | 0 | 1 | DF | QD | ||||||
| 125739241 | 12573924 | 9 | C | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | PERSONALLY ADMINISTERED | 0 | |||||||||||
| 125739241 | 12573924 | 10 | C | MEFENAMIC ACID. | MEFENAMIC ACID | 1 | 3 DOSAGE FORMS DAILY; | 2705.875 | DF | 0 | 1 | DF | TID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125739241 | 12573924 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125739241 | 12573924 | Abdominal pain upper | |
| 125739241 | 12573924 | Nausea | |
| 125739241 | 12573924 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125739241 | 12573924 | 1 | 20160629 | 0 | ||
| 125739241 | 12573924 | 2 | 20160311 | 0 | ||
| 125739241 | 12573924 | 3 | 20160629 | 0 | ||
| 125739241 | 12573924 | 4 | 20150709 | 0 | ||
| 125739241 | 12573924 | 5 | 20151214 | 0 | ||
| 125739241 | 12573924 | 6 | 20150616 | 0 | ||
| 125739241 | 12573924 | 7 | 20140109 | 0 | ||
| 125739241 | 12573924 | 8 | 20150302 | 0 | ||
| 125739241 | 12573924 | 9 | 20160527 | 20160528 | 0 | |
| 125739241 | 12573924 | 10 | 20140109 | 0 |